October 15 - 16, 2020 | Dallas

Jack Jacobs

speaker photo BIOTECH


Zhittya Genesis Medicine Inc.

Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, multiple sclerosis, and enhance stroke recovery.

Speaker Schedule